Metraipolis › archive › dc_3572ea0907a5

Emerging biomarkers of immune checkpoint inhibitor toxicity in triple-negative breast cancer: a mini-review — Europe PMC PMID:42774612

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42774612
DOI
10.3389/fimmu.2026.1950429
License (as archived)
solo-consultazione
Archived
2026-10-15T21:40:58.737Z
SHA-256 of the archived text
d572ecafe89becff00d8fc866bebaa1af7559908eb0130ae7420faf650c66918
Stable URL of this page
https://metraipolis.com/documento/dc_3572ea0907a5

How to cite

Emerging biomarkers of immune checkpoint inhibitor toxicity in triple-negative breast cancer: a mini-review — Europe PMC PMID:42774612 — Europe PMC (en), https://europepmc.org/article/MED/42774612 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3572ea0907a5 (Metraipolis archive dc_3572ea0907a5, sha256 d572ecafe89becff00d8fc866bebaa1af7559908eb0130ae7420faf650c66918)
BibTeX
@misc{dc3572ea0907a5,
  title = {Emerging biomarkers of immune checkpoint inhibitor toxicity in triple-negative breast cancer: a mini-review — Europe PMC PMID:42774612},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42774612},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3572ea0907a5; sha256 d572ecafe89becff00d8fc866bebaa1af7559908eb0130ae7420faf650c66918},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42774612. Agents can read the archived copy with the MCP tool read_document.